Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 720250, 5 pages
http://dx.doi.org/10.1155/2015/720250
Research Article

Blunted Activation of Rho-Kinase in Yak Pulmonary Circulation

1Department of Fundamental Nursing and Medicine, University of Fukui, Fukui 910-1193, Japan
2Department of Respiratory Medicine, Kanazawa Medical University, Ishikawa 920-0265, Japan
3Department of Health Science, Matsumoto University, Matsumoto 390-1295, Japan
4Life Science Research Laboratory, University of Fukui, Fukui 910-1193, Japan
5Laboratory of Molecular and Cell Biology, Institute of Molecular Biology and Medicine, 720040 Bishkek, Kyrgyzstan
6Excellence Cluster Cardio-Pulmonary System, Universities of Giessen & Marburg Lung Center, 35392 Giessen, Germany
7Department of General Surgery, Kyrgyz State Medical Academy, 720020 Bishkek, Kyrgyzstan
8Department of Internal Medicine, University of Fukui, Fukui 910-1193, Japan

Received 12 August 2014; Revised 17 October 2014; Accepted 24 October 2014

Academic Editor: Harm Jan J. Bogaard

Copyright © 2015 Takeshi Ishizaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. F. Grover, “Pulmonary circulation in animals and man at high altitude,” Annals of the New York Academy of Sciences, vol. 127, no. 1, pp. 632–639, 1965. View at Google Scholar · View at Scopus
  2. H. H. Hecht, H. Kuida, R. L. Lange, J. L. Thorne, and A. M. Brown, “Brisket disease. II. Clinical features and hemodynamic observations in altitude-dependent right heart failure of cattle,” The American Journal of Medicine, vol. 32, no. 2, pp. 171–183, 1962. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Tucker, I. F. McMurtry, J. T. Reeves, A. F. Alexander, D. H. Will, and R. F. Grover, “Lung vascular smooth muscle as a determinant of pulmonary hypertension at high altitude,” American Journal of Physiology, vol. 228, no. 3, pp. 762–767, 1975. View at Google Scholar · View at Scopus
  4. M. Maggiorini and F. Léon-Velarde, “High-altitude pulmonary hypertension: a pathophysiological entity to different diseases,” European Respiratory Journal, vol. 22, no. 6, pp. 1019–1025, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. H. A. Ghofrani, R. Voswinckel, F. Reichenberger et al., “Hypoxia- and non-hypoxia-related pulmonary hypertension—established and new therapies,” Cardiovascular Research, vol. 72, no. 1, pp. 30–40, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. P. Harris, D. Heath, P. Smith et al., “Pulmonary circulation of llama at high and low altitudes,” Thorax, vol. 37, no. 1, pp. 38–45, 1982. View at Publisher · View at Google Scholar · View at Scopus
  7. I. S. Anand, E. Harris, R. Ferrari, and P. Pearce, “Pulmonary haemodynamics of the yak, cattle, and cross breeds at high altitude,” Thorax, vol. 41, no. 9, pp. 696–700, 1986. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Sakai, G. Ueda, Y. Yanagidaira, M. Takeoka, G. Tang, and Y. Zang, “Physiological characteristics of pika, ochotona, high-altitude adapted animals,” in High-Altitude Medical Science, G. Ueda and N. F. Voelkel, Eds., pp. 99–107, Shinshu University Press, Matsumoto, Japan, 1988. View at Google Scholar
  9. A. G. Durmowicz, S. Hofmeister, T. K. Kadyraliev, A. A. Aldashev, and K. R. Stenmark, “Functional and structural adaptation of the yak pulmonary circulation to residence at high altitude,” Journal of Applied Physiology, vol. 74, no. 5, pp. 2276–2285, 1993. View at Google Scholar · View at Scopus
  10. T. Koizumi, Z. Ruan, A. Sakai et al., “Contribution of nitric oxide to adaptation of tibetan sheep to high altitude,” Respiratory Physiology & Neurobiology, vol. 140, no. 2, pp. 189–196, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. T. Ishizaki, T. Koizumi, Z. Ruan, Z. Wang, Q. Chen, and A. Sakai, “Nitric oxide inhibitor altitude-dependently elevates pulmonary arterial pressure in high-altitude adapted yaks,” Respiratory Physiology and Neurobiology, vol. 146, no. 2-3, pp. 225–230, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. Pullamsetti, L. Kiss, H. A. Ghofrani et al., “Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension,” FASEB Journal, vol. 19, no. 9, pp. 1175–1177, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. V. Sauzeau, E. Le Mellionnec, J. Bertoglio, E. Scalbert, P. Pacaud, and G. Loirand, “Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase,” Circulation Research, vol. 88, no. 11, pp. 1102–1104, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Wang, N. Jin, S. Ganguli, D. R. Swartz, L. Li, and R. A. Rhoades, “Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction,” American Journal of Respiratory Cell and Molecular Biology, vol. 25, no. 5, pp. 628–635, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. T. Nagaoka, Y. Morio, N. Casanova et al., “Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 287, no. 4, pp. L665–L672, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. Z. Do.e, Y. Fukumoto, A. Takaki et al., “Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension,” Circulation Journal, vol. 73, no. 9, pp. 1731–1739, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. X.-F. Ming, H. Viswambharan, C. Barandier et al., “Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells,” Molecular and Cellular Biology, vol. 22, no. 24, pp. 8467–8477, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Laufs and J. K. Liao, “Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase,” The Journal of Biological Chemistry, vol. 273, no. 37, pp. 24266–24271, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Rikitake and J. K. Liao, “Rho GTPases, statins, and nitric oxide,” Circulation Research, vol. 97, no. 12, pp. 1232–1235, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Takemoto, J. Sun, J. Hiroki, H. Shimokawa, and J. K. Liao, “Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase,” Circulation, vol. 106, no. 1, pp. 57–62, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Zhou and J. K. Liao, “Rho kinase: an important mediator of atherosclerosis and vascular disease,” Current Pharmaceutical Design, vol. 15, no. 27, pp. 3108–3115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Sauzeau, H. Le Jeune, C. Cario-Toumaniantz et al., “Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle,” The Journal of Biological Chemistry, vol. 275, no. 28, pp. 21722–21729, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. B. S. Zuckerbraun, D. A. Stoyanovsky, R. Sengupta et al., “Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA,” The American Journal of Physiology—Cell Physiology, vol. 292, no. 2, pp. C824–C831, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. T. P. Robertson, M. Dipp, J. P. T. Ward, P. I. Aaronson, and A. M. Evans, “Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat,” British Journal of Pharmacology, vol. 131, no. 1, pp. 5–9, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. K. A. Fagan, M. Oka, N. R. Bauer et al., “Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 287, no. 4, pp. L656–L664, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. J.-M. Hyvelin, K. Howell, A. Nichol, C. M. Costello, R. J. Preston, and P. McLoughlin, “Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation,” Circulation Research, vol. 97, no. 2, pp. 185–191, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. B. Kojonazarov, A. Myrzaakhmatova, T. Sooronbaev, T. Ishizaki, and A. Aldashev, “Effects of fasudil in patients with high-altitude pulmonary hypertension,” European Respiratory Journal, vol. 39, no. 2, pp. 496–498, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. J. H. Newman, T. N. Holt, L. K. Hedges et al., “High-altitude pulmonary hypertension in cattle (brisket disease): candidate genes and gene expression profiling of peripheral blood mononuclear cells,” Pulmonary Circulation, vol. 1, pp. 462–469, 2011. View at Publisher · View at Google Scholar · View at PubMed
  29. L. Weigand, J. T. Sylvester, and L. A. Shimoda, “Mechanisms of endothelin-1-induced contraction in pulmonary arteries from chronically hypoxic rats,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 290, no. 2, pp. L284–L290, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. Sakurada, H. Okamoto, N. Takuwa, N. Sugimoto, and Y. Takuwa, “Rho activation in excitatory agonist-stimulated vascular smooth muscle,” American Journal of Physiology: Cell Physiology, vol. 281, no. 2, pp. C571–C578, 2001. View at Google Scholar · View at Scopus
  31. Y. X. Wang, V. da Cunha, B. Martin-Mcnulty et al., “Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein e deficient mice,” European Journal of Pharmacology, vol. 512, no. 2-3, pp. 215–222, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. S.-I. Satoh, K. Kawasaki, I. Ikegaki, T. Asano, and H. Shimokawa, “Evidence of a direct cellular protective effect of Rho-kinase inhibitors on endothelin-induced cardiac myocyte hypertrophy,” Biochemical and Biophysical Research Communications, vol. 424, no. 2, pp. 338–340, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. K. Takeda, T. Ichiki, T. Tokunou et al., “Critical role of rho-kinase and MEK/EFK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 5, pp. 868–873, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Guilluy, S. Eddahibi, C. Agard et al., “RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling,” The American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 12, pp. 1151–1158, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. M. Oka, N. Homma, L. Taraseviciene-Stewart et al., “Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats,” Circulation Research, vol. 100, no. 6, pp. 923–929, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus